E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -15.53% -18.17%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -38.74% -38.94%
Operating Income 38.74% 38.94%
Income Before Tax 39.06% 47.80%
Income Tax Expenses -- --
Earnings from Continuing Operations 39.06% 47.80%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 39.06% 47.80%
EBIT 38.74% 38.94%
EBITDA 39.35% 39.32%
EPS Basic 39.58% 48.06%
Normalized Basic EPS 39.27% 39.23%
EPS Diluted 39.58% 48.06%
Normalized Diluted EPS 39.27% 39.23%
Average Basic Shares Outstanding 0.88% 0.48%
Average Diluted Shares Outstanding 0.88% 0.48%
Dividend Per Share -- --
Payout Ratio -- --